BioOptics World reports that US biophotonic device developer BioPhotas has received FDA clearance of its Celluma light emitting diode (LED) light therapy device. It has been designed for acne treatment, muscle and joint pain, muscle and joint stiffness, muscle spasm, arthritis and compromised local blood circulation.

 

They say that research funded by the National Aeronautics and Space Administration and the Defense Advanced Research Projects Agency, using LEDs or biophotonic therapy, has been proven in clinical trials to up-regulate cellular function in the treatment of a number of common conditions, restoring the body's natural ability to heal itself.

 

In some other therapies, tissue is intentionally damaged to create a healing response whereas LED light can re-energise cellular function in a non-invasive manner.

 

The Celluma device uses three wavelengths of LED light energy, modulated with proprietary electronic algorithms.